Results 201 to 210 of about 699,568 (298)

Liberal or restrictive transfusion in high-risk patients after hip surgery.

open access: yesNew England Journal of Medicine, 2011
J. Carson   +17 more
semanticscholar   +1 more source

Maternal morbidity following a trial of labor after cesarean birth: A scoping review of operative vaginal birth compared with cesarean birth in the second stage of labor

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Abstract Background Increased use of operative vaginal birth (OVB; forceps and vacuum) has been proposed as a strategy to avoid cesarean birth (CB) among individuals who elect a trial of labour after CB (TOLAC). The relative maternal safety of OVB and CB in individuals with a TOLAC is poorly understood. Objective To summarize the available evidence and
Irina I. Oltean   +2 more
wiley   +1 more source

Risk factors for blood transfusion during cesarean section in women with major placenta previa. [PDF]

open access: yesSci Rep
Baev E   +6 more
europepmc   +1 more source

Some Hematologic Parameters of Blood Donors at the National Blood Transfusion Service (NBTS), Jos, Nigeria

open access: bronze, 2019
Lugos MD   +9 more
openalex   +1 more source

Addressing gaps in international blood availability and transfusion safety in low‐ and middle‐income countries: a NHLBI workshop

open access: yesTransfusion, 2018
B. Custer   +12 more
semanticscholar   +1 more source

Hemostatic abnormalities at the time of fetal death: A retrospective study evaluating the prevalence and relevance of targeted testing

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective To assess the prevalence of hemostasis abnormalities at the time of fetal death diagnosis. Methods This retrospective single‐center study included all fetal deaths between 22 and 42 weeks from July 2017 to December 2023, excluding multiple pregnancies, patients on anticoagulant therapy, and those with known pre‐existing coagulation ...
Chloé Lieng   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy